By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Five Prime Therapeutics, Inc. 

1650 Owens Street
Suite 200
San Francisco  California  94158  U.S.A.
Phone: 415-365-5600 Fax: 415-365-5601


Company News
Five Prime (FPRX) Welcomes Garry Nicholson To Board Of Directors 5/16/2017 10:55:17 AM
Five Prime (FPRX) Announces First Quarter 2017 Results And Provides Business Update 5/5/2017 11:33:22 AM
Five Prime (FPRX) To Announce First Quarter 2017 Financial Results And Host Conference Call On May 4 4/21/2017 11:04:46 AM
Five Prime (FPRX) Announces Completion Of Enrollment For The Phase II Part Of The Ongoing Trial Of Cabiralizumab For The Treatment Of Pigmented Villonodular Synovitis (PVNS) 4/11/2017 10:57:36 AM
Juno (JUNO), Five Prime (FPRX) are Quiet Winners at AACR 4/21/2016 6:16:52 AM
Bad News for Bay Area's Five Prime (FPRX) as GlaxoSmithKline (GSK) Walks Away from Cancer Drug Pact 3/11/2016 7:36:53 AM
Sneak Peak of Five Prime (FPRX)'s Prelim Phase I Tumor Data Leaves Investors Happy 1/22/2016 6:24:02 AM
Five Prime (FPRX) Appoints Drug Development Leaders To Board Of Directors 12/4/2015 8:04:37 AM
Five Prime (FPRX) To Present At The Oppenheimer 26th Annual Healthcare Conference 12/2/2015 8:17:46 AM
Five Prime (FPRX) Begins Dose Expansion In Gastric Cancer Patients With FGFR2b Over-Expression In Phase I Trial Of FPA144 11/20/2015 7:53:42 AM